Welcome
Support Centre
19 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
'In-house' referrals : a primary care alternative to immediate secondary care referrals.
ISRCTN ISRCTN60533639
ClinicalTrials.gov identifier
Public title 'In-house' referrals : a primary care alternative to immediate secondary care referrals.
Scientific title
Acronym N/A
Serial number at source PSI06-24
Study hypothesis Methods are needed to ensure that those patients referred from primary to secondary care are those most likely to benefit. In-house referral is the referral of a patient by a general practitioner to another general practitioner within the same practice for a second opinion on the need for secondary care referral. To describe whether in-house referral is practical and acceptable to patients, and the health outcomes for patients.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Not applicable: Not applicable
Participants - inclusion criteria Patients judged to need hospital referral by their general practitioners. In the intervention practices, these patients were initially referred `in-house¿ to another GP in the same practice. In control practices, patients were referred directly to hospital.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/04/1995
Anticipated end date 01/04/1997
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Practices were randomized into an intervention or a control group. In intervention practices, patients with certain conditions who were about to be referred to secondary care were referred in-house. If the second clinician agreed referral was appropriate the patient was referred on to secondary care. In control practices patients were referred in the usual fashion. Patient satisfaction and health status was measured at the time of referral, 6 months and one year.
Primary outcome measure(s) 1. Health status: SF 36
2. Patient Satisfaction: MISS
Secondary outcome measure(s) Not provided at time of registration
Sources of funding NHS Primary and Secondary Care Interface National Research and Development Programme
Trial website
Publications
Contact name Dr  Paul  Kinnersley
  Address Department of General Practice
University of Wales College of Medicine
Llanedeyrn Health Centre
Maelfa
  City/town Cardiff
  Zip/Postcode CF23 9PN
  Country United Kingdom
  Tel +44 (0)29 2054 1133
  Fax +44 (0)29 2954 0129
  Email Kinnersley@cf.ac.uk
Sponsor Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 21/11/2005
Date ISRCTN assigned 23/01/2004
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central